-
May 1: The Week in Cancer NewsAt the AACR Virtual Annual Meeting I, researchers presented new data on cancer biology, treatment, screening and risk reduction.
by Cancer Today Staff
-
April 24: The Week in Cancer NewsA third of cancer survivors report that they or their partners have stayed in jobs due to concerns about keeping health insurance, and the Food and Drug Administration approves a new treatment for metastatic triple-negative breast cancer.
by Kate Yandell
-
April 17: The Week in Cancer NewsA study shows that antibiotic use prior to starting immunotherapy for melanoma is associated with decreased survival, and the Food and Drug Administration approves a treatment for advanced HER2-positive breast cancer.
by Kate Yandell
-
April 10: The Week in Cancer NewsA study indicates that the rate of e-cigarette use is elevated in young adults with a history of cancer, and oncologists write about the impact of COVID-19.
by Kate Yandell
-
April 3: The Week in Cancer NewsCAR-T cell therapy shows promise for treating mantle cell lymphoma, and the Food and Drug Administration requests that drugmakers pull the anti-heartburn drug ranitidine due to concerns about a contaminant that may increase cancer risk.
by Kate Yandell
-
March 27: The Week in Cancer NewsCancer patients and survivors share tips for coping with the uncertainty and isolation brought on by the coronavirus, and the coronavirus is impacting cancer clinical trials and treatment.
by Kate Yandell and Marci A. Landsmann
-
March 20: The Week in Cancer NewsThe spread of the coronavirus is having an impact on cancer care, and the Food and Drug Administration will require cigarette packaging and advertisements to come with new graphic warning labels.
by Kate Yandell
-
March 13: The Week in Cancer NewsExperts offer information and cancer centers take precautions in light of the novel coronavirus, and the Food and Drug Administration approves an immunotherapy combination for liver cancer.
by Kate Yandell
-
March 6: The Week in Cancer NewsA report shows that colorectal cancer incidence is decreasing in older adults while simultaneously rising in younger individuals, and the Food and Drug Administration approves a new treatment for multiple myeloma.
by Kate Yandell
-
February 28: The Week in Cancer NewsResearchers find one possible explanation for the link between certain gut bacteria and colorectal cancer, and a study shows that the rate of appendix cancer is rising.
by Kate Yandell
Scientists present data on the risks of immune checkpoint inhibitors so more patients can tap into the treatment.
by Marci A. Landsmann
Tissue and Liquid Biopsy for Targeted TherapyTailored treatments led to better outcomes than standard of care when biomarker results from liquid biopsy and tumor tissue aligned.
by Eric Fitzsimmons
Cancer Vaccines Show Promise in Early TrialsWhile mRNA vaccines offer a personalized approach to triggering an immune response, peptide vaccines could be a one-size-fits-all treatment. Researchers are exploring both options.
by Thomas Celona
Declining Breast Cancer Mortality in Younger WomenU.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
